| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.5B | $12.6B | $12.5B | $12.2B | $12.4B | $11.8B | $3.3B | $3.5B |
| Cost of Revenue | $1.9B | $1.9B | $2.0B | $2.0B | $2.0B | $2.0B | $2.2B | $2.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $0.5B | $1.0B | $0.8B | $1.4B | $1.1B | $0.7B | $0.2B |
| Net Income | $0.5B | $-0.5B | $-0.1B | $0.0B | $0.2B | $0.5B | $-0.4B | $-0.3B |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-3.27 | $-2.91 |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-3.27 | $-2.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $14.1B | $14.5B | $14.7B | $15.2B | $16.0B | $15.6B | $15.9B |
| Current Assets | $3.2B | $3.3B | $3.2B | $3.1B | $3.5B | $4.5B | $3.4B | $3.5B |
| Cash & Equivalents | $0.3B | $0.0B | $0.0B | $0.1B | $0.5B | $1.7B | $0.2B | $0.2B |
| Total Liabilities | $14.0B | $15.4B | $15.3B | $15.4B | $16.0B | $17.1B | $17.2B | $16.8B |
| Current Liabilities | $2.2B | $2.3B | $2.1B | $2.2B | $2.4B | $2.8B | $2.3B | $2.4B |
| Stockholders' Equity | $-1.4B | $-1.9B | $-1.4B | $-1.4B | $-1.4B | $-1.6B | $-2.2B | $-1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.2B | $0.3B | $-0.1B | $2.2B | $0.4B | $0.3B |
| Investing Cash Flow | $0.8B | $-0.3B | $-0.0B | $-0.3B | $-0.5B | $0.2B | $-0.0B | $-0.2B |
| Capital Expenditures | $0.3B | $0.4B | $0.5B | $0.4B | $0.5B | $0.4B | $0.4B | $0.5B |
| Financing Cash Flow | $-1.2B | $-0.2B | $-0.3B | $-0.4B | $-0.5B | $-0.9B | $-0.4B | $-0.4B |